Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria

Journal of Clinical Pathology

Volumn 63, Issue 12, 2010, Pages 1121-1123

  Todorova, I ^a   Ganchev, G ^b   Shikova, Evelina ^a  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^b National Specialized Hospital for Active Treatment in Oncology   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; VIRUS DNA;

ADULT; AGED; ARTICLE; BULGARIA; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; NEOPLASM INVASIVENESS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 78649630751     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.080168     Document Type: Article

References (22)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Bosch FX, de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
4. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) StudyGroup. J Natl Cancer Inst 1995;87:796-802.
5. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121:621-32.
6. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-85.
7. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
8. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in Bulgaria, 2007. http://www.who.int/hpvcentre/publications/HPVReport2007.pdf.
9. Arbyn M, Primic-Zakelj M, Raifu AO, et al. The burden of cervical cancer in south-east Europe at the beginning of the 21st century. Coll Antropol 2007;31(Suppl 2):7-10.
10. Arbyn M, Autier P, Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 2007;18:1423-25.
11. Arbyn M, Raifu AO, Bray F, et al. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009;45:2685-708.
12. de Sanjosé S, Alemany L, Castellsagué X, et al. Human papillomavirus vaccines and vaccine implementation. Womens Health (Lond Engl) 2008;4:595-604.
13. Castellsagué X, Schneider A, Kaufmann AM, et al. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 2009;115:S15-23.
14. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
15. Baay MF, Quint WG, Koudstaal J, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996;34:745-7.
16. Birner P, Bachtiary B, Dreier B, et al. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol 2001;14:702-9.
17. Sideri M, Cristoforoni P, Casadio C, et al. Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine 2009;27(Suppl 1):A30-3.
18. Usubütün A, Alemany L, Küçükali T, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009;28:541-8.
19. Schwartz SM, Daling JR, Shera KA, et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001;19:1906-15.
20. Burger RA, Monk BJ, Kurosaki T, et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996;88:1361-8.
21. Koffa M, Koumantakis E, Ergazaki M, et al. Detection of ras gene mutations and HPV in lesions of the human female reproductive tract. Int J Oncol 1994;5:189-95.
22. Karlsen F, Kalantari M, Chitemerere M, et al. Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest 1994;71:604-11.